2024 Year-in-Review

A poster for 2024 year in review for solving kids ' cancer

Advancing Childhood Cancer Research: SKC’s 2024 Milestones

Dear Friends and Supporters,


As we look back on 2024, I want to extend my heartfelt thanks to every donor, volunteer, and partner who has stood with us. Because of you, Solving Kids’ Cancer has been able to push forward with groundbreaking research and open new doors to treatments for children facing the toughest cancers. Your support fuels our work and brings hope to families in their most difficult moments.


At Solving Kids’ Cancer, our mission goes beyond research — it’s about making sure children with cancer are at the forefront of every breakthrough. When so much competes for attention in the medical field, kids with rare cancers can sometimes be overlooked. We’re here to make sure they’re not left behind, focusing on research that leads to real solutions kids can access sooner. This year, we’ve seen exciting progress in immunotherapy, targeted treatments, and personalized care, bringing us closer to a future where more children can overcome cancer.

New Cancer Breakthroughs in Research

This year, Solving Kids’ Cancer made significant strides in childhood cancer research. Here are some highlights:

A purple icon of a target with an arrow in it.
  • Advancing Brain Tumor Research: With the help of our partners, we’ve made strides in treating high-risk brain tumors. Quarterly conferences brought top experts together, setting the stage for new clinical trials and treatments.
  • Solving Indolent Neuroblastoma: This project focuses on developing diagnostic tools and new childhood cancer treatments for slow-growing neuroblastoma. This year, we created a test for ALT biomarkers, established nine patient-derived neuroblastoma models, and identified PF-06821497 as a promising drug to enhance outcomes.
  • New Steps in Immunotherapy: We are working to make immunotherapy a stronger option for children with hard-to-treat cancers like medulloblastoma. This year’s research is expected to lead to clinical trials in 2025, moving these treatments closer to young patients.

Leadership in Collaboration and Advocacy

Collaboration is key at Solving Kids’ Cancer. We teamed up with global partners and made sure children’s needs were at the center of our efforts:

A handshake with a globe in the background.
  • Pediatric Brain Tumor Research Network (PBTRN): Partnering with Columbia University, we launched this network to connect researchers from around the world, aiming to speed up brain tumor treatments for children.
  • Advocating for High-Risk Brain Tumor Treatments: SKC joined the Pediatric Strategy Forum to push for new therapies for diffuse midline gliomas (DMG), advocating against placebo trials and for innovative childhood cancer treatments targeting SMARCA4 and GD2.
  • Shaping Clinical Trial Design: Our advocacy led the Children’s Oncology Group (COG) to make a landmark decision for trial ANBL2431, which will compare chemo-immunotherapy1 with a reduced transplant regimen. This decision highlights the growing role of patient advocacy in research and treatment protocols.

Our Research in the Spotlight

Solving Kids’ Cancer’s research contributions reached new heights this year through key publications and media features

A magnifying glass is looking at a stack of papers and a graph.
  • FDA Approval of IWILFIN: After 15 years of effort, we celebrated the FDA’s approval of IWILFIN, a neuroblastoma maintenance therapy. This approval shows the power of long-term advocacy and partnership.
  • Innovative GD2BATs Immunotherapy Trial: We shared results from a clinical trial using GD2BATs2 — an immunotherapy that equips T cells with antibodies to target cancer cells in neuroblastoma and osteosarcoma. The study showed this approach is safe and effective, bringing new hope to families facing these tough cancers.
  • Influencing Future Clinical Trials: Our published paper, “To transplant, or not to transplant? That is the question,”3 offered vital insights on using autologous stem cell transplant (ASCT) in high-risk neuroblastoma. By examining evidence and parent views, we encouraged new patient-centered approaches.

Events That Brought Us Together

From fundraising events to community gatherings, we connected with our community throughout the year:

A group of people are standing in a circle holding hands.
  • Comedy Fights Kids’ Cancer: Hosted by comedian Seth Herzog, this event gave our supporters a night of laughter while raising vital funds for our work.
  • Summer Luncheon in the Hamptons: Our eighth annual luncheon gathered advocates and donors to celebrate our progress and rally even more backing for research.
  • That’s Good Sports Fundraiser: This live-streamed fundraising event during the Broncos vs. Saints game brought sports fans together in a fun way to fuel childhood cancer research.


Thanks to the incredible commitment of our community, these events reinforced our mission to build a world where no child faces cancer alone.

Keep Advancing Childhood Cancer Research with Us

Each child battling cancer deserves a real chance at a cure, and every new discovery brings us one step closer. Your support helps launch new treatments, brings together experts to find solutions, and offers hope to families facing the toughest challenges.


This holiday season, your gift can directly impact these children and families. There’s still so much more to be done, and every dollar will help drive new cancer breakthroughs forward, advancing life-saving work that gives kids the chance they deserve.

MAKE YOUR TAX-DEDUCTABIBLE GIFT TODAY!

Thank you for being part of this journey. Your support is making a difference, one child at a time.


With deep gratitude,

A black and white signature of scott on a white background.

Scott Kennedy

Executive Director & Co-Founder

Solving Kids’ Cancer

Sources

  1. National Library of Medicine – Chemotherapy: A New Trend in Cancer Treatment https://pmc.ncbi.nlm.nih.gov/articles/PMC10252089/
  2. National Library of Medicine – Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3xanti-GD2 bispecific antibody armed T cells https://pubmed.ncbi.nlm.nih.gov/38519053/
  3. National Library of Medicine – To transplant, or not to transplant? That is the question. A patient advocate evaluation of autologous stem cell transplant in neuroblastoma https://pubmed.ncbi.nlm.nih.gov/35373890/
A man and a little girl are sitting in front of a wooden wall.
By duda November 20, 2024
Ahana’s Story of Strength with High-Risk Neuroblastoma Every day, over 1,000 children worldwide are diagnosed with cancer,1 and for many families, that diagnosis means facing an uncertain future. At just 20 months old, Ahana was diagnosed with a rare and aggressive cancer that had already spread through her small body. Her family’s search for life-saving childhood cancer treatments led them from South Africa to Spain and possibly toward a clinical trial in New York. Ahana’s journey shows the importance of supporting organizations like Solving Kids’ Cancer, which works to find, fund, and advocate for advanced treatments that give hope to families fighting against tough-to-treat rare pediatric cancers.
A group of children are holding a sign that says `` lace up for kids 2024 ''.
October 1, 2024
Lace Up for Kids: Your Impact on Childhood Cancer Research At Solving Kids’ Cancer, our mission has always been driven by hope — hope for better treatments, hope for breakthroughs, and most importantly, hope for every child fighting cancer. This year’s Lace Up for Kids campaign was nothing short of inspiring. Together, we’ve raised over $264,000 across the entire campaign, funding innovative childhood cancer research and providing more treatment options for children in need.  From coast to coast, nearly 4,000 participants have stepped up to lace up their gold shoelaces and make a difference. Whether it was through schools, sports teams, or community groups, the show of support has been overwhelming throughout the years. Over 7,823 donations have been made to accelerate new treatments, and the hashtag #CareWearShare has been used 13,864 times, spreading the message far and wide!
A girl is standing in front of a car in a parking lot.
September 2, 2024
Gold Laces for Childhood Cancer Awareness Month: Erin’s Story 
A group of children are standing in a circle with their shoes on the floor.
August 8, 2024
Smithtown Goes Gold for Childhood Cancer Awareness Month!
A poster for lace up for kids with a butterfly on it
August 6, 2024
Childhood Cancer Awareness Month: Lace Up for Kids 2024
A man standing on top of a mountain with the words osteosarcoma survivor to surgeon dr. kurt weiss ' story
August 1, 2024
Osteosarcoma Survivor to Surgeon: Dr. Kurt Weiss’ Story
Jacob 's journey : a childhood cancer survivor 's story
May 10, 2024
Jacob’s Journey: A Childhood Cancer Survivor’s Story Every battle has its heroes, and among the bravest are young children like Jacob Mozer, who faced stage 4 high-risk neuroblastoma when he was barely old enough to walk. Diagnosed at only 16 months old, Jacob’s early years were filled with constant medical appointments and intense treatments. Despite these challenges, today, Jacob is a shining example of the remarkable progress in pediatric oncology. He’s not merely surviving; he’s thriving as a pharmacy resident, driven to give back to the medical community that gave him a second chance at life. During National Cancer Survivors Month this June, we honor and celebrate fighters like Jacob who have battled cancer and emerged stronger. This month also serves to amplify the conversation about pediatric cancer survivorship and push for vital research that continues to save lives. Solving Kids’ Cancer (SKC) plays an essential role in this effort, supporting children like Jacob by funding crucial clinical trials that enhance survival rates and improve the quality of life for those fighting fatal childhood cancers.
A close up of a person holding a test tube in a laboratory.
May 2, 2024
Trailblazing Treatments for Pediatric Brain Tumors Picture a fortress built to guard precious treasure but accidentally also keeps out the very allies it needs in a time of crisis. This is the challenge faced by medical researchers when dealing with the brain’s natural defense — the blood-brain barrier — especially in children with brain tumors. At Columbia University Medical Center, Dr. Luca Szalontay is leading the charge to breach this fortress with groundbreaking approaches. Recently, Dr. Timothy Cripe from Solving Kids’ Cancer’s podcast, This Week in Pediatric Oncology (TWIPO) , interviewed Dr. Szalontay to delve deeper into these innovative treatments. This Brain Tumor Awareness Month, we’re shining a light on these important advances in treating children’s cancer. Understanding the Challenge Treating pediatric brain tumors like diffuse midline glioma (DMG) is especially tough because of the brain’s own protective shield, known as the blood-brain barrier. This barrier keeps out most chemotherapy drugs as well as large molecules, like antibodies, making it hard to treat the tumors effectively. Dr. Szalontay describes the dilemma: “Our field hasn’t been able to advance as quickly as it has with leukemias or other solid tumors because the drugs don’t penetrate the brain efficiently.” She adds on the nature of this blood-brain barrier, “It’s evolutionary, very important to protect us from different toxins and harmful agents, but this is a shield which protects the tumor as well.” Even when drugs work well in lab tests, they struggle to get to the tumor in strong enough doses without harming the body. Dr. Szalontay also points out that DMG tumors are found in very sensitive areas of the brain, making traditional surgery or radiation risky because they could damage vital brain functions. This makes finding safe and effective treatments for these tumors even more challenging. So, what’s being done to tackle these obstacles and help kids fight these tumors?
A group of stick figures are holding hands around a globe.
April 4, 2024
World Health Day: Pediatric Cancer’s Global Divide Imagine this: Two children, born at the same moment, oceans apart. In a country brimming with medical resources, one child quickly gets top-notch treatment for cancer. Meanwhile, across the globe, the other child faces a drastically different reality, with limited access to basic care. This isn’t just a thought experiment — it’s the harsh truth of pediatric cancer treatment worldwide. Observed every year on April 7, World Health Day shines a light on the mission to make healthcare accessible for all. This day is particularly significant in the context of pediatric cancer, where vast disparities in treatment availability highlight the global challenge of ensuring every child has the opportunity for health and healing. The Stark Contrast in Survival Rates: A Look at Pediatric Cancer Statistics Every day, more than 1,000 children are diagnosed with cancer, and the chances of survival vary greatly depending on where they live.1 Pediatric cancer survival rates serve as a clear indicator of the disparities between high-income countries (HICs) and low- and middle-income countries (LMICs). In wealthier nations such as the United States and Western Europe, the 5-year survival rate for children with cancer is over 80%, thanks to advanced healthcare systems and access to the latest treatments.2 But, here’s a troubling childhood cancer statistic: in LMICs where 80% of children with cancer live, fewer than 20% survive.1 This gap is due to several factors, including late diagnoses or, tragically, no diagnosis at all. Many children succumb to the disease without access to pain medication, and the burdens of travel and the high costs force most families to abandon care. These challenges are compounded by limited access to necessary treatments,3 as well as a lack of specialized equipment and trained healthcare professionals needed for effective pediatric cancer treatment. Addressing this divide requires a concerted global effort to improve early detection, make treatments more affordable, and enhance healthcare infrastructures, giving every child a fair chance to beat cancer. Navigating the Access Maze Access to cancer care shouldn’t be a treasure hunt. Yet, for many in LMICs, it feels like that — a relentless search for something seemingly out of reach. Here’s the reality revealed in childhood cancer statistics worldwide: many areas lack enough doctors who specialize in children’s cancer4 and the prices of cancer drugs can be sky-high.2 Even getting to a hospital can be an ordeal, with some families traveling hundreds of miles. And the financial strain? Devastating. The cost of care can quickly add up to more than a year’s income, forcing households into deep financial distress. In many LMICs, the lack of comprehensive insurance coverage means families are often left to pay for pediatric cancer treatment entirely out-of-pocket.5 Families often face the impossible choice between their child’s health and their financial survival. Solving Kids’ Cancer: Bridging the Gap Solving Kids’ Cancer (SKC) isn’t standing by; we’re on the front lines, actively working to make a difference in the global pediatric cancer landscape. Beyond funding research, advocating for policy changes, and fostering global partnerships, SKC is committed to educating and empowering the community to take action. We understand that while we might not have a global foothold to address every aspect of the pediatric cancer divide directly, there’s power in collective action. Through our efforts, we aim to catalyze advancements in pediatric cancer treatments and care that could dramatically change outcomes for children worldwide. • Research: We direct funds into cutting-edge studies, searching for breakthrough treatments that promise a brighter future for all kids, regardless of where they live. • Advocacy: We advocate for children’s needs by steering research funding towards unmet challenges and collaborating with experts to prioritize all children, including expanding trials to international sites to maximize access.2 • Global Partnerships: We don’t do it alone. By teaming up with researchers, hospitals, and other organizations across the globe, we’ve helped fund clinical trials that have extended to over 250 institutions across 15 countries worldwide . Uniting for a Cause Solving Kids’ Cancer extends its mission beyond research by fostering community and collaboration. Our signature event, Lace Up for Kids , held annually during September Childhood Cancer Awareness Month, is a powerful testament to this mission, drawing communities together to stand in solidarity against childhood cancer. Additionally, supporters can create their own fundraiser and have a platform to engage their local communities, sparking crucial conversations and garnering support for the cause. These initiatives highlight an important fact: While the challenge of pediatric cancer is significant, each of us has a part to play. By working together and supporting each other, we can fund the research needed to possibly change the direction of pediatric cancer treatment and care worldwide. World Health Day: A Chance for Every Child The fight against pediatric cancer is a stark reminder of the work ahead of us.6 It’s a battle that Solving Kids’ Cancer is dedicated to, but we need more than just our efforts — we need a global movement. This World Health Day, let’s rally for every child’s right to fight cancer on an even playing field. Donate today to help fund more innovative research and one day find a cure for childhood cancer — because every child, no matter where they are born, deserves a chance — a chance to fight, a chance to survive, and a chance to thrive.
A woman is hugging another woman in front of a doctor.
March 18, 2024
Childhood Cancer Resource: 7 Things to Do After Diagnosis Nothing can ever prepare a parent for the moment they learn their child has cancer. As reality sets in, so does the question: “What comes next?” To help navigate this challenging time, Scott Kennedy, SKC Executive Director, and Donna Ludwinski, SKC Director of Research Advocacy offer some insights. Both have personal experience with the emotional and practical aspects of this journey, having faced their own children’s cancer battles. They’ve dedicated themselves to improving treatment options for the most difficult-to-treat cancers, drawing from their personal experiences and professional expertise. Scott, motivated by his son Hazen’s fight, co-founded Solving Kids’ Cancer, while Donna, driven by her son Erik’s journey, has contributed to pediatric cancer research on a global scale. Their insights can serve as a valuable childhood cancer resource for families facing a diagnosis. Here are 7 essential steps they recommend parents and caregivers consider: 1. Educate Yourself About the Disease Facing a new and scary diagnosis can feel overwhelming, but gaining knowledge about your child’s cancer can be one of the most powerful tools in your arsenal. “Understanding your child’s cancer is the first step towards empowerment,” Scott advised, “Start by learning as much as you can about your child’s specific type of cancer. Utilize reputable online resources and pediatric cancer resources to gather information. This knowledge will help you to make informed decisions and ask the right questions when discussing treatment options with your child’s medical team.” To give you a head start, here’s a list of questions you can ask your child’s oncologist about their specific cancer type. 2. Create a Community of Support Drawing from her extensive experience advocating for parents and families, Donna emphasized the value of building a support network and strengthening family bonds: “It takes a village to navigate the challenges of childhood cancer. Seek out childhood cancer support groups for guidance and shared understanding; Reach out to friends and family who can offer a helping hand with daily tasks, such as meal preparation, household chores, and caring for other siblings, to conserve your energy for where it’s needed most.” Creating a community of support is not just about logistical help; it’s a source of emotional strength . Donna also highlighted, “Make sure to keep open communication within the family to help acknowledge everyone’s feelings and fears.” Sharing this journey can bring a family closer in unexpected ways. 3. Keep a Record of Everything Keeping track of medical information might seem daunting, but it’s a crucial step in managing your child’s care. Scott suggested, “Start a binder or digital folder to store all the important documents and notes you take. This habit will not only keep you organized but also make you feel more prepared for appointments and discussions with your child’s healthcare team.” 4. Advocate for Your Child “Never underestimate the power of a parent’s intuition,” Donna shared. “You know your child best, and in the medical world, your voice is critical.” She reminded that parents and guardians should fully understand the medical information presented and not shy away from asking questions or expressing concerns to their child’s doctors. Here is a glossary to help you understand medical terms related to oncology. Adding to her advice, Donna highlighted, “Seeking second opinions is also part of advocating for your child . It’s about exploring all options and being confident in the treatment plan.” To help drive changes in treatments and care, she also encouraged parents and caregivers to get involved in pediatric cancer advocacy. 5. Prioritize Self-Care Scott, whose son Hazen bravely battled cancer, knows firsthand how mentally and emotionally taxing this journey can be for a parent. He stresses the benefits of self-care: “In the midst of caring for your child, don’t forget to take care of yourself too. It’s essential to carve out moments for self-care , even if brief.” Whether enjoying a quiet cup of coffee in the morning or taking a short walk in the evening, finding small ways to recharge can significantly enhance your ability to stay strong and supportive of your child. 6. Where to Go for Treatment If the diagnosis is made by a pediatrician or general practitioner, a child is typically referred to the nearest Children’s Oncology Group (COG) hospital. The child’s oncologist will make a treatment recommendation based on a standard protocol, or recommend enrollment on a current frontline clinical trial. In most cases, the closest COG hospital will treat your child the same as any other hospital. Some very rare childhood cancers do not have standard protocols and are treated based on tumor board recommendations, and different approaches may be available at other large centers.  7. When to Request Additional Testing While some pediatric cancers, like leukemia and lymphomas, have seen profound increases in survival rates with advanced treatments, there remain some tumor types that are difficult to treat. If you are facing a less favorable prognosis, talk to your oncologist about additional testing that may reveal targets that can be treated with new drugs or immunotherapies. Many rare tumor types are now being treated based on genetic mutations or antigen expression.
More Posts